Literature DB >> 6875612

Quantitative testing of handgrip strength, myotonia, and fatigue in myotonic dystrophy.

C Torres, R T Moxley, R C Griggs.   

Abstract

An electrically calibrated, isometric hand dynamometer was used to quantitate maximum voluntary contraction (MVC(, relaxation time and fatigue time (at 50% MVC) in 18 normal and 10 myotonic dystrophy subjects. Precise measurements of MVC and fatigue time were obtained in normals and myotonic dystrophy patients. Relaxation times were markedly prolonged and were quite variable in all patients with myotonic dystrophy in contrast to the highly reproducible times in normals. Neither "warm-up" activity nor acetazolamide treatment altered relaxation time.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6875612     DOI： 10.1016/0022-510x(83)90135-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  10 in total

1.  Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.

Authors:  Zhen Zhi Tang; Viktor Yarotskyy; Lan Wei; Krzysztof Sobczak; Masayuki Nakamori; Katy Eichinger; Richard T Moxley; Robert T Dirksen; Charles A Thornton
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

2.  Static dynamometer for the measurement of multidirectional forces exerted by the thumb.

Authors:  D Bourbonnais; P Duval
Journal:  Med Biol Eng Comput       Date:  1991-07       Impact factor: 2.602

3.  Nifedipine in the treatment of myotonia in myotonic dystrophy.

Authors:  R Grant; D L Sutton; P O Behan; J P Ballantyne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

Review 4.  Clinical evaluation of membrane excitability in muscle channel disorders: potential applications in clinical trials.

Authors:  James C Cleland; Eric L Logigian
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 5.  Endurance time is joint-specific: a modelling and meta-analysis investigation.

Authors:  Laura A Frey Law; Keith G Avin
Journal:  Ergonomics       Date:  2010-01       Impact factor: 2.778

Review 6.  The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Authors:  E Matthews; D Fialho; S V Tan; S L Venance; S C Cannon; D Sternberg; B Fontaine; A A Amato; R J Barohn; R C Griggs; M G Hanna
Journal:  Brain       Date:  2009-11-16       Impact factor: 13.501

7.  Relationships between grip strength, myotonia, and CTG expansion in myotonic dystrophy type 1.

Authors:  Jean-Yves Hogrel; Gwenn Ollivier; Isabelle Ledoux; Luc J Hébert; Bruno Eymard; Jack Puymirat; Guillaume Bassez
Journal:  Ann Clin Transl Neurol       Date:  2017-11-07       Impact factor: 4.511

Review 8.  What is known about the effects of exercise or training to reduce skeletal muscle impairments of patients with myotonic dystrophy type 1? A scoping review.

Authors:  Marie-Pier Roussel; Marika Morin; Cynthia Gagnon; Elise Duchesne
Journal:  BMC Musculoskelet Disord       Date:  2019-03-05       Impact factor: 2.362

9.  Antisense oligonucleotide and adjuvant exercise therapy reverse fatigue in old mice with myotonic dystrophy.

Authors:  Ningyan Hu; Eunjoo Kim; Layal Antoury; Jia Li; Paloma González-Pérez; Seward B Rutkove; Thurman M Wheeler
Journal:  Mol Ther Nucleic Acids       Date:  2020-11-26       Impact factor: 8.886

10.  Muscle Ultrasound Shear Wave Elastography as a Non-Invasive Biomarker in Myotonia.

Authors:  Cornelius Kronlage; Alexander Grimm; Alyssa Romano; Jan-Hendrik Stahl; Pascal Martin; Natalie Winter; Justus Marquetand
Journal:  Diagnostics (Basel)       Date:  2021-01-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.